共 29 条
[3]
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (vol 26, pg 1547, 2015)
[J].
ANNALS OF ONCOLOGY,
2017, 28 (11)
:2901-2905
[4]
Department of Medical Affairs, 2023, Med. J. Peking Union Med. Coll. Hosp, V14, P706, DOI [10.12290/xhyxzz.2023-0315, DOI 10.12290/XHYXZZ.2023-0315]
[5]
Dong A., 2022, Shanghai Nursing, V22, P27, DOI [10.3969/j.issn.1009-8399.2022.05.006, DOI 10.3969/J.ISSN.1009-8399.2022.05.006]
[7]
Cancer incidence and mortality in China, 2022 ☆
[J].
JOURNAL OF THE NATIONAL CANCER CENTER,
2024, 4 (01)
:47-53